Margins will get smashed while CardioCel is in scale-up mode.
Thats not what the market is looking for.
Revenue growth is key. CardioCel sales.
CardioCel revenue has come in at ~$56k, a whopping 1294% above PCP.
Okay, it's a bit silly to quote %'s when coming from a base of $4k, but I figured that some of you might like that one.
half yearly report announced, page-4
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.55 |
Change
-0.130(1.11%) |
Mkt cap ! $244.1M | |||
| Open | High | Low | Value | Volume |
| $11.71 | $11.89 | $11.41 | $703.3K | 60.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2 | $11.55 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.83 | 500 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |